Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-050949
Filing Date
2022-09-21
Accepted
2022-09-21 19:39:42
Documents
1
Period of Report
2022-09-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2826
  Complete submission text file 0001209191-22-050949.txt   4198
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Issuer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address
Kantoff Philip W. (Reporting) CIK: 0001866025 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37410 | Film No.: 221257646